(2021). Brigatinib in ALK-positive non-small cell lung cancer: Real-world data in the Latin American population (Bri-world extend CLICaP).
Chicago Style (17th ed.) CitationBrigatinib in ALK-positive Non-small Cell Lung Cancer: Real-world Data in the Latin American Population (Bri-world Extend CLICaP). 2021.
MLA (8th ed.) CitationBrigatinib in ALK-positive Non-small Cell Lung Cancer: Real-world Data in the Latin American Population (Bri-world Extend CLICaP). 2021.
Warning: These citations may not always be 100% accurate.